Abstract
Background Paediatric brain tumour survivors can have neurocognitive deficits that negatively impact their quality of life, but it is unclear if deficits are primarily caused by treatments, such as radiotherapy, or manifest earlier due to the tumour and related complications. The aim of this work is to characterise white matter injury caused by brain tumours, unrelated to treatment effects, and explore heterogeneity in these white matter abnormalities between individual patients.
Methods We used diffusion tensor imaging (DTI) and Neurite Orientation Dispersion Diffusion Imaging (NODDI) to assess white matter injury in 8 posterior fossa tumour patients. A novel one-against-many approach was used by comparing an individual patient to 20 age- and sex-matched healthy controls to assess variability in white matter abnormalities between the posterior fossa tumour patients. White matter was analysed at presentation (prior to treatment), post-surgery (24-72 hours after surgery), and at follow-up (3-18 months after surgery).
Results We demonstrate white matter abnormalities in 5 posterior fossa tumour patients before treatment, likely related to tumour-induced hydrocephalus, which persisted after treatment. White matter changes were complex and patient-specific, and group-based comparisons with control sub-jects may fail to detect these individual abnormalities.
Conclusions Identifying pre-treatment white matter injury in posterior fossa tumour patients highlights the importance of personalised assessment of brain microstructure, which should be considered in minimising neurocognitive deficits to improve patient quality of life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
EDM is funded by the UCL EPSRC CDT i4health (grant reference EP/ S021930/1), and EDM and DRH are funded by the NIHR Great Ormond Street Hospital Biomedical Research Centre (NIHR-INF-2647). JAD is supported by the Radiation Research Unit at the Cancer Research UK City of London Centre Award [C7893/A28990].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for this study was granted as a retrospective case note review by the Joint Research and Development Office at Great Ormond Street Hospital and UCL Great Ormond Street Institute of Child Health under 23NC04. Healthy children were included in the analysis, for comparison to patients, originally recruited to existing ethically approved departmental studies, including UK Bromley Research Ethics Committee (REC 12/LO/0442), Research Ethics Service Committee London - Riverside (REC 14/LO/0115), London - West London & GTAC Research Ethics Committee (REC 15/LO/0347), London - London Bridge Research Ethics Committee (REC 16/LO/0256), UCL Institute of Education (REC approval number 1080), and London - Bloomsbury Research Ethics Committee (10/H0713/16).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- AD
- axial diffusivity;
- CSI
- craniospinal irradiation;
- CSF
- cerebral spinal fluid;
- DMG
- diffuse midline glioma;
- DTI
- diffusion tensor imaging;
- FA
- fractional anisotropy;
- GOSH
- Great Ormond Street Hospital for Children;
- HB
- hemangioblastoma;
- HGG
- high-grade glioma;
- MB
- medulloblastoma;
- MD
- mean diffusivity;
- MRI
- magnetic resonance imaging;
- NODDI
- Neurite Orientation Dispersion Diffusion Imaging;
- ODI
- orientation dispersion index;
- PA
- pilocytic astrocytoma;
- PVWM
- periventricular white matter;
- RD
- radial diffusivity;
- TBSS
- tract-based spatial statistics.
